Dr Nitzan Rosenfeld
Senior Group Leader
Cancer Research UK Cambridge Institute
Nitzan trained in Physics, and specialized in quantitative molecular biology, obtaining a Ph.D. in the field of Systems Biology from the Weizmann Institute of Science. In 2005 he joined Rosetta Genomics Limited, where he was head of Computational Biology and led development of molecular diagnostic tests. Since 2009 he is a group leader at the Cancer Research UK Cambridge Institute. His translational research group focuses on the application of circulating tumour DNA as a tool for cancer diagnostics and non-invasive genomics. In 2013 Nitzan was awarded the CRUK Future Leaders in Cancer Research prize, the British Association for Cancer Research Translational Research Award, and an ERC Starting Grant. In 2014, Nitzan and his colleagues founded Inivata, a clinical cancer genomics company that aims to harness the emerging potential of circulating DNA analysis to improve testing and treatment for oncologists and their patients.